Nouveau Life Pharmaceuticals, Inc.
NOUV · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2008 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $0 | $5 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $0 | $5 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | 0 | 0 | -0 | -0.004 |
| % Growth | – | 100% | 95.2% | – |
| Operating Cash Flow | – | – | – | $0 |
| Capital Expenditures | – | – | – | $0 |
| Free Cash Flow | – | – | – | $0 |